Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is intended to show whether inhaled chemotherapy can be added to a standard IV
chemotherapy regime, to investigate the additional toxicities and to show initial evidence of
efficacy of the combination.